CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new treatment for progressive multiple sclerosis by creating anti-TNFR1 antibody-loaded collagen spheres. The approach focuses on assessing their neuroprotective effects in preclinical models, addressing a significant gap in current progressive MS therapies.
Multiple sclerosis (MS) is a chronic inflammatory immune-mediated demyelinating disease of the central nervous system (CNS), which affects 700,000 people in Europe, with total annual healthcare costs of over €27.3 billion.
Current available treatments for progressive MS have modest effects on relapse symptoms but do not modify disease progression.
Critically there are currently no licensed disease-modifying treatments for progressive MS.
My strategy will represent a disease modifying treatment f…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
